| Scrip Code | 530871 |
|---|---|
| NSE Symbol | CHEMBOND |
| MSEI Symbol | NOTLISTED |
| ISIN | INE995D01025 |
| Name of company | CHEMBOND MATERIAL TECHNOLOGIES LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 16-01-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 08-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 16-01-2026 11:00:00 |
| End date and time of board meeting | 16-01-2026 17:15:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 6,289.52 | 17,832.03 | |
| Other income | 155.54 | 433.24 | |
| Total income | 6,445.06 | 18,265.27 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 3,738.10 | 10,354.16 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (34.30) | 79.99 |
| (d) | Employee benefit expense | 982.54 | 2,801.30 |
| (e) | Finance costs | 12.69 | 29.79 |
| (f) | Depreciation, depletion and amortisation expense | 81.04 | 269.49 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 1,188.90 | 3,433.15 |
| Total other expenses | 1,188.90 | 3,433.15 | |
| Total expenses | 5,968.97 | 16,967.88 | |
| 3 | Total profit before exceptional items and tax | 476.09 | 1,297.39 |
| 4 | Exceptional items | (179.61) | (179.61) |
| 5 | Total profit before tax | 296.48 | 1,117.78 |
| 6 | Tax expense | ||
| 7 | Current tax | 155.11 | 297.04 |
| 8 | Deferred tax | (17.48) | (119.86) |
| 9 | Total tax expenses | 137.63 | 177.18 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 158.85 | 940.60 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 158.85 | 940.60 |
| 17 | Other comprehensive income net of taxes | (1.57) | 0.83 |
| 18 | Total Comprehensive Income for the period | 157.28 | 941.43 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 158.86 | 940.59 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 1.57 | 0.82 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 672.41 | 672.41 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 1.18 | 6.99 | |
| Diluted earnings (loss) per share from continuing operations | 1.18 | 6.99 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 1.18 | 6.99 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 1.18 | 6.99 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | As per PDF file submitted to the Stock Exchanges |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Speciality Chemical | 4,908.25 | 14,759.53 | ||||
| 2 | Animal Health | 1,103.56 | 3,072.49 | ||||
| Total Segment Revenue | 6,011.81 | 17,832.02 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 6,011.81 | 17,832.02 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Speciality Chemical | 147.89 | 486.24 | ||||
| 2 | Animal Health | 172.66 | 377.90 | ||||
| Total Profit before tax | 320.55 | 864.14 | |||||
| i. Finance cost | 0.00 | 0.00 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | (155.54) | (433.24) | |||||
| Profit before tax | 476.09 | 1,297.38 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Speciality Chemical | 19,464.55 | 19,464.55 | ||||
| 2 | Animal Health | 1,489.21 | 1,489.21 | ||||
| Total Segment Asset | 20,953.76 | 20,953.76 | |||||
| Un-allocable Assets | 0.00 | 0.00 | |||||
| Net Segment Asset | 20,953.76 | 20,953.76 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Speciality Chemical | 3,681.42 | 3,681.42 | ||||
| 2 | Animal Health | 949.72 | 949.72 | ||||
| Total Segment Liabilities | 4,631.14 | 4,631.14 | |||||
| Un-allocable Liabilities | 0.00 | 0.00 | |||||
| Net Segment Liabilities | 4,631.14 | 4,631.14 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Amount of items that will not be reclassified to profit and loss | (1.94) | 1.57 |
| Total Amount of items that will not be reclassified to profit and loss | (1.94) | 1.57 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (0.37) | 0.74 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | (1.57) | 0.83 |
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | M/s. Kastury & Talati, Chartered Accountants | Yes | 30-06-2026 | ||
|---|---|---|---|---|---|